Researchers at Georgia Tech have developed a new AI-based app, MyPath, that adapts to each stage of a patient’s cancer journey with personalized resources and recommendations on everything from side effects to insurance and more.

Thanks to an increasing demand of AI technology for research and drug development, the AI in healthcare market size is expected to exceed $13 billion by 2025, according to a report by Global Market Insights.

Anne Klibanski, MD, has been named interim president and CEO of Partners HealthCare. Klibanski’s current leadership responsibilities within the Partners system include research, academia and clinical work. She will succeed CEO David Torchiana, MD, who recently announced his plans to retire at the end of April. 

CMS has proposed covering a new form of cancer therapy, CAR T-cell therapy, under Medicare. The proposal would create a uniform standard of covering the treatment, which uses a patient’s own immune system to fight the disease.

Researchers from the Imperial College London and the University of Melbourne created a new AI algorithm that is four times more accurate in predicting survival rates among ovarian cancer patients. The tool was also able to determine the most effective treatment for patients who exhibit ovarian cancer. Research findings were published in Nature Communications.

If healthcare is to rise to the challenge of providing better care while holding the line on costs, stakeholders across the entire industry must collaborate around digesting data and serving patients.

Flagler Hospital, a 335-bed community hospital based in St. Augustine, Florida, is projected to save more than $20 million after AI technology helped it reduce costs, average length of stay and readmissions for pneumonia patients. 

Medical device company Sight Diagnostics has raised $27.8 million in funding to expand its system that uses AI to analyze blood tests, according to a report by VentureBeat.

It will take close collaboration between governmental bodies and private businesses to achieve interoperability across U.S. healthcare. There’s no big news in that. However, a high-powered panel fleshed out the details on the necessity Feb. 14 at HIMSS19 in Orlando.

Catch up on all things fraud and ethics around the healthcare industry with HealthExec’s weekly watchdog report.